News - Galenica

Filter

Current filters:

Galenica

Popular Filters

Vifor gets certain rights to Helsinn's netupitant-palonosetron

16-05-2013

Privately-held Helsinn Healthcare and fellow Switzerland-based Vifor Pharma, part of the Galenica group…

EisaiEuropeGalenicaHelsinnLicensingnetupitantOncologypalonosetronPharmaceuticalVifor Pharma

US FDA sets new PDUFA action date for Vifor's Injectafer NDA

08-04-2013

Vifor Pharma, a unit of Switzerland's Galenica Group (SIX: GALN), says that its US partner, Luitpold…

Daiichi SankyoFerinjectGalenicaInjectaferLuitpold PharmaNorth AmericaPharmaceuticalRegulationVifor Pharma

Vifor Fresenius PA21 filed for approval with US FDA, accepted by EMA

11-02-2013

A New Drug Application for PA21 (iron(III)-oxyhydroxide) has been submitted to the US Food and Drug Administration.…

EuropeFreseniusGalenicaNephrology and HepatologyNorth AmericaPA21PharmaceuticalRegulationVifor Pharma

Observational study suggests a role for Vifor's Ferinject for anemic and iron deficient patients with cancer

31-01-2013

Swiss firm Vifor Pharma, a subsidiary of the Galenica Group (GALN: SIX), notes the publication of an…

FerinjectGalenicaOncologyPharmaceuticalResearchVifor Pharma

Regulatory filing preparations underway for Vifor's PA21 on good Ph III results

09-07-2012

The pivotal Phase III clinical study shows that the new phosphate binder PA21 successfully controls hyperphosphatemia…

FreseniusGalenicaNephrology and HepatologyPA21PharmaceuticalRegulationResearchVifor Pharma

Vifor to distribute Debiopharm's Pamorelin in Switzerland

15-05-2012

Swiss independent drug developer Debiopharm) and Switzerland-based Vifor Pharma - part of Galenica (SIX:…

DebiopharmEuropeGalenicaLicensingMen's HealthOncologyPamorelinPharmaceuticalSalvacylVifor Pharma

Galenica acquires Spanish JV Vifor Uriach and Grupo Uriach's primary care business

15-11-2011

Swiss drugmaker Galenica (SIX: GALN) has acquired all the outstanding shares of Vifor Uriach Pharma SL,…

GalenicaMergers & AcquisitionsPharmaceuticalUriach

Vifor Pharma ties up with Hikma for Ferinject in Middle East and North Africa

17-08-2011

Switzerland-based Vifor Pharma, a subsidiary of the Galenica Group (GALN: SIX), has entered into a collaboration…

FerinjectFinancialGalenicaHikma PharmaceuticalsLicensingPharmaceuticalRest of the WorldVifor Pharma

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top